Neuerscheinungen 2012Stand: 2020-01-07 |
Schnellsuche
ISBN/Stichwort/Autor
|
Herderstraße 10 10625 Berlin Tel.: 030 315 714 16 Fax 030 315 714 14 info@buchspektrum.de |
Sandra M. McLachlan, Basil Rapoport
(Beteiligte)
Gravesī Disease
Pathogenesis and Treatment
Herausgegeben von Rapoport, Basil; McLachlan, Sandra M.
2012. xiii, 307 S. 14 SW-Abb. 235 mm
Verlag/Jahr: SPRINGER, BERLIN 2012
ISBN: 1-461-36983-5 (1461369835)
Neue ISBN: 978-1-461-36983-7 (9781461369837)
Preis und Lieferzeit: Bitte klicken
From the perspective of the investigator, Gravesī disease is a fascinating disorder with unique features and opportunities for study. The discovery in 1956 that Gravesī disease was caused by a humoral factor, later shown to be an antibody to the TSH receptor, was a triumph for modern investigative medicine. Rapid progress is now being made in (i) understanding the molecular interaction between autoantibodies and the TSH receptor, (ii) identifying the genes that contribute to the predisposition to disease, (iii) developing an animal model of Gravesī disease, and (iv) identifying the long-sought orbital antigen in ophthalmopathy. From the clinical standpoint, although Gravesī disease is eminently treatable, there is no definitive cure. None of the therapeutic options are ideal. It is hoped that rapid progress in understanding the pathogenesis of the disease will lead to the ultimate goal of some form of immunotherapy that will make antithyroid drugs, radioiodine and thyroidectomy obsolete.
The chapters in Gravesī Disease: Pathogenesis and Treatment represent the viewpoints of many prominent clinicians and investigators working in the field. The editors are grateful for their contributions which cover an unusually comprehensive compendium of subjects relating to the disease.
List of Contributors. Preface. 1. Gravesī disease - a historical perspective; R. Volpé, C. Sawin. 2. Epidemiology of Gravesī disease; D. Phillips. 3. The genetics of familial and non-familial hyperthyroid Gravesī disease; Y. Tomer, T.F. Davies. 4. Thyroid autoantibodies in Gravesī disease; B. Rapoport, S.M. McLachlan. 5. T cells and the autoimmune response to the TSH receptor; S.M. McLachlan, B. Rapoport. 6. Cytokines in Gravesī disease; R.A. Ajjan, et al. 7. Co-stimulatory molecules in Gravesī disease; F. Paolieri, et al. 8. Apoptosis in autoimmune thyroid disease; P. Wu, J.R. Baker, Jr. 9. Animal models of Gravesī disease; M. Ludgate, et al. 10. Thionamide drug therapy; M.M. Kaplan, D.A. Meier. 11. Radioiodine therapy of Gravesī disease; M.D. Gross, et al. 12. Surgical therapy of Gravesī disease; O. Alsanea, O.H. Clark. 13. Management of Gravesī disease in children; S.A. Rivkees. 14. Pregnancy and Gravesī disease; J.H. Lazarus. 15. Neonatal Gravesī disease; M. Zakarija, J.M. McKenzie. 16. Thyrotoxicosis and the heart; W. Dillman. 17. Iodine and Gravesī disease; P.H.K. Eng, L.E. Braverman. 18. Pathogenesis of Gravesī ophthalmopathy; R.S. Bahn. 19. Therapy of Gravesī ophthalmopathy; L. Wartofsky, et al. 20. Radioiodine therapy and Gravesī ophthalmopathy; L. Bartalena, et al. 21. Gravesī dermopathy; T.J. Smith. Index.